Companies: 10,795·Total market cap: $144.5T
DA32 Life Science Tech Acquisition Corp.

DA32 Life Science Tech Acquisition Corp.

DALSNASDAQFinancial Services
$10.30
$-0.02(-0.19%)
Market Cap$264195000
P/E Ratio
52W High$11.22
52W Low$9.68
SEC Filings

DA32 Life Science Tech Acquisition Corp. (DALS) SEC Filings & 10-K Annual Reports

SEC EDGAR regulatory submissions (10-K, 10-Q, 8-K), latest forms, and full filing history — quick links to financials and earnings below.

SEC EDGAR · data.sec.gov · CIK 0001863294 · DALS · NASDAQ · as of Jun 8, 2026

Filing snapshot

77
Total Filings
SC 13G/A
Latest Form
2024-02-07
Most Recent
2021
Filing Since

Source: SEC EDGAR (data.sec.gov) · CIK 0001863294 · Updated hourly · Not investment advice

Latest Annual Report

10-K · Annual ReportFY
Filed Date
2023-03-29
Fiscal Year End
Mar 29, 2023
Accession No.
0001193125-23-083849
Primary Document
d440273d10k.htm
Source: data.sec.gov · CIK 0001863294 · Accession 0001193125-23-083849

Latest Key Filings

10-QQuarterly Report
10-Q
2023-05-12
8-KCurrent Report
8-K
2023-07-21Material Event
Form 4Insider Activity
Ownership Change Disclosures

Executive & director trade disclosures. Full buy/sell sentiment analysis on the dedicated tab.

SEC Filing History

Hide Form 4 / 144
SC 13G/ABeneficial Ownership Report (Amended)
FORM SC 13G/A
2024-02-07
View
SC 13G/ABeneficial Ownership Report (Amended)
13G/A DALS
2023-09-11
View
SC 13G/ABeneficial Ownership Report (Amended)
Beneficial Ownership Report (Amended)
2023-08-08
View
15-12G15-12G
15-12G
2023-08-08
View
SC 13D/ASC 13D/A
ARCH VENTURE FUND XI, L.P. - DA32 LIFE SCIENCE -- SCH 13G/A(#1)
2023-08-04
View
SC 13D/ASC 13D/A
SC 13D/A
2023-08-02
View
SC 13D/ASC 13D/A
SC 13D/A
2023-08-01
View
SC 13D/ASC 13D/A
SC 13D/A
2023-08-01
View
25-NSE25-NSE
25-NSE
2023-07-28
View
8-KCurrent Report
8-K
2023-07-21
View
SC 13G/ABeneficial Ownership Report (Amended)
SC 13G/A
2023-05-15
View
10-QQuarterly Report
10-Q
2023-05-12
View
SC 13GBeneficial Ownership Report
DALS 13G
2023-04-10
View
10-KAnnual Report
FORM 10-K
2023-03-29
View
SC 13G/ABeneficial Ownership Report (Amended)
FORM SC 13G/A
2023-02-14
View
Showing 1–15 of 63 filingsForm 4 / 144 hidden· 77 total in EDGAR

About SEC Filings & 10-K Annual Reports

Data source: SEC EDGAR (data.sec.gov)  |  Updated: Hourly  |  CIK: 0001863294  |  Exchange: NASDAQ · Financial Services

DA32 Life Science Tech Acquisition Corp. (NASDAQ: DALS) has submitted 77 documents to the U.S. Securities and Exchange Commission (SEC) since its IPO in 2021. As a Financial Services sector company with CIK 0001863294, all filings are publicly accessible via the EDGAR database at no cost.

The annual 10-K report is DA32 Life Science Tech Acquisition Corp.'s most comprehensive regulatory disclosure. The most recent DA32 Life Science Tech Acquisition Corp. 10-K was filed on 2023-03-29 for fiscal year ending 2023. Historical DALS 10-K annual reports are available from 2021 through 2023.

Investors researching DA32 Life Science Tech Acquisition Corp. SEC filings can access 10-K annual reports, quarterly 10-Q reports, material event 8-K filings, and proxy statements directly from the links above. All documents are sourced from the official SEC EDGAR system.

Source: SEC EDGAR · data.sec.gov · SEC Form 10-K · SEC Form 10-Q · SEC Form 8-K2026-06-08

Frequently Asked Questions

DALS SEC Filings · 8 questions

DA32 Life Science Tech Acquisition Corp. (DALS) SEC filings are publicly available on this page and on the official SEC EDGAR database at sec.gov. You can browse all 77 filings and access original documents at no cost. DA32 Life Science Tech Acquisition Corp.'s CIK is 0001863294.

DALS SEC filingsDA32 Life Science Tech Acquisition Corp. SEC documentsfind DALS 10-K